Loading...
Evaluation of Biosimilars for Formulary Inclusion: Factors for Consideration by P&T Committees
P&T committees will play a key role in driving the adoption of biosimilars, which have unique characteristics compared with small-molecule generic drugs. Key elements of formulary review will include clinical parameters, product characteristics, and institutional considerations, which are among...
Saved in:
| Published in: | P T |
|---|---|
| Main Author: | |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MediMedia USA, Inc.
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4606858/ https://ncbi.nlm.nih.gov/pubmed/26535024 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|